Company Filing History:
Years Active: 2017
Title: Zhi Chen: Innovator in Pharmaceutical Crystallization
Introduction
Zhi Chen is a notable inventor based in Taizhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystal forms of medications. His work focuses on enhancing the properties of pharmaceutical compounds to improve their efficacy and stability.
Latest Patents
Zhi Chen holds a patent for the "Crystal form of dabigatran etexilate mesylate and preparation method and use thereof." This invention relates to novel crystal forms M and N of dabigatran etexilate mesylate. The X-Ray powder diffractogram of crystal form M exhibits characteristic peaks at specific 2θ diffraction angles, while crystal form N has its own distinct set of peaks. These crystal forms demonstrate excellent properties in terms of leaching time, biological release, chemical stability, and processing adaptability.
Career Highlights
Zhi Chen is associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical research and development. His innovative work has contributed to advancements in drug formulation and delivery systems.
Collaborations
Zhi Chen has collaborated with notable colleagues, including Liang Zhang and Chuan Liu, to further enhance the research and development efforts within his field.
Conclusion
Zhi Chen's contributions to pharmaceutical crystallization exemplify the importance of innovation in improving drug formulations. His work not only advances scientific knowledge but also has practical implications for the pharmaceutical industry.